Aim The aim of the study is to evaluate the prognostic value of b2-m as a biochemical parameter for the diagnosis and prognosis of oral squamous cell carcinoma (SCC). Materials and Methods The study included 60 patients (15 oral SCC, 15 leukoplakia, 15 individuals exposed to various carcinogens and without oral cancerous or precancerous lesions, 15 healthy individuals). The levels of b2-m were estimated using chemi-luminescent immunometric assay on Immulite fully automated machine. Statistical analysis of the data was done using Tuckey's test, ANOVA and independent sample t test. Results Results showed that b2-m was increased in individuals exposed to carcinogens without precancerous and cancerous lesion. Conclusion Serum b2-m can be used as a better indicator and can give an early indication of malignant change and therefore malignancy can be detected at an early and treatable stage.